Add Yahoo as a preferred source to see more of our stories on Google. Zhongmou Therapeutics’ gene therapy for advanced retinitis pigmentosa (RP) has shown promise in a first-in-human trial. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results